1973
Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival.
Young R, Corder M, Berard C, DeVita V. Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival. JAMA Internal Medicine 1973, 131: 446-54. PMID: 4574227, DOI: 10.1001/archinte.131.3.446.Peer-Reviewed Original Research
1972
Delayed hypersensitivity in Hodgkin's disease A study of 103 untreated patients
Young R, Corder M, Haynes H, DeVita V. Delayed hypersensitivity in Hodgkin's disease A study of 103 untreated patients. The American Journal Of Medicine 1972, 52: 63-72. PMID: 5058359, DOI: 10.1016/0002-9343(72)90008-3.Peer-Reviewed Original ResearchConceptsSkin test reactivityPeripheral lymphocyte countTest reactivityHodgkin's diseaseLymphocyte countUntreated patientsPrognostic signSkin testAbsolute peripheral lymphocyte countLymphocyte-depleted Hodgkin's diseaseMean absolute lymphocyte countIncidence of anergyStage IV diseaseAbsolute lymphocyte countBad prognostic signDuration of remissionFrequency of relapsesTime of diagnosisStage of diseaseUseful prognostic signCutaneous anergyPeripheral lymphocytopeniaMixed cellularityMumps antigenNodular sclerosis
1971
Delayed Hypersensitivity in Patients with Cancer
Corder M, Young R, DeVita V. Delayed Hypersensitivity in Patients with Cancer. New England Journal Of Medicine 1971, 285: 522-524. PMID: 5558895, DOI: 10.1056/nejm197108262850917.Peer-Reviewed Original ResearchAnergy and tryptophan metabolism in Hodgkin’s disease
DeVita V, Chabner B, Livingston D, Oliverio V. Anergy and tryptophan metabolism in Hodgkin’s disease. American Journal Of Clinical Nutrition 1971, 24: 835-840. PMID: 5091524, DOI: 10.1093/ajcn/24.7.835.Peer-Reviewed Original Research
1970
Abnormalities of Tryptophan Metabolism and Plasma Pyridoxal Phosphate in Hodgkin's Disease
Chabner B, DeVita V, Livingston D, Oliverio V. Abnormalities of Tryptophan Metabolism and Plasma Pyridoxal Phosphate in Hodgkin's Disease. New England Journal Of Medicine 1970, 282: 838-843. PMID: 5418547, DOI: 10.1056/nejm197004092821504.Peer-Reviewed Original ResearchConceptsHodgkin's diseaseUntreated patientsPlasma levelsPlasma pyridoxal phosphate levelsPlasma pyridoxal phosphatePyridoxal phosphate levelsAdvanced diseaseComplete remissionSymptomatic diseaseImmunosuppressive effectsAbnormal resultsPyridoxine deficiencyNormal limitsTryptophan metabolismPatientsDiseasePyridoxal phosphatePhosphate levelsDeficiencyL-tryptophanLittle evidenceMetabolismRemissionChemotherapyAnemia
1969
Familial chronic lymphocytic leukemia.
Fraumeni J, Vogel C, DeVita V. Familial chronic lymphocytic leukemia. Annals Of Internal Medicine 1969, 71: 279-84. PMID: 4184386, DOI: 10.7326/0003-4819-71-2-279.Peer-Reviewed Original Research